Durbin Requests GAO Inquiry On Supplement Adverse Event Reports
This article was originally published in The Tan Sheet
Sen. Durbin says it is unclear how FDA’s adverse event reporting system works to protect consumer safety and asks GAO to investigate the agency’s collection and analysis of dietary supplement AERs.
You may also be interested in...
The dietary supplement industry looks to FDA's Hydroxycut investigation for a sign on whether the agency will analyze adverse event reports more closely following a high-profile product recall
Key congressional leaders want to give FDA tighter control over dietary supplements, saying a Government Accountability Office report critical of the agency's enforcement supports granting additional authority
One of Congress' most vocal critics of dietary supplements, Sen. Dick Durbin, likely will have greater clout under the Obama presidency, with increased regulation of supplements a likely personal priority